Report Number : 8747-001
Market Dynamics 1999 Migraine: Seven-Country Analysis & Perspective
Countries Covered : World
Date : 1999 Price : £ 2,995

Report Number : 8747-002
Medical Diagnostic Imaging
Evaluation of latest products on the market and their applications in all therapeutic areas, including cancer, cardiology, neurology, obstetrics, gynaecology and surgery. Profiles of market leaders; evaluation of critical market factors and predictions until 2007. Analysis of all major imaging modalities, including CT, MRI, nuclear medicine imaging, X-ray, ultrasound, optical and thermal imaging and PACS
Countries Covered : World
Date : 2002 Price : £ 750

Report Number : 8747-002C
Nucleic Acid Testing: Technologies & Markets
Trends and opportunities in NAT technologies and clinical applications; major players and their strategies. Review of applications in blood-borne viral infections, personalised medicine, cardiovascular disease, and HPV.cervical cancer screening; profiles 20 key global players and their strategies for success
Countries Covered : World
Scope : 184pp Date : 2001 Price : £ 695

Report Number : 8747-002E
Global Diagnostic Oncology Markets
Market profile of the products, country markets and companies successful in the field of cancer screening and diagnostics. Details of national screening programmes; reviews of demographics and other environmental factors for the major cancer types; discussion of the new and emerging technologies and their likely impact on the market
Countries Covered : World
Date : 2001 Price : £ 695

Report Number : 8747-002G
Proteomics
Strategies for growth in the diagnostic and pharmaceutical industries. Overview of the global market, together with market forecasts and information on key geographical locations. Also includes 10 detailed case studies into the leading market players and insight into developing technologies
Countries Covered : World
Scope : 112pp Date : 2001 Price : £ 695

Report Number : 8747-002K
Strategies and Opportunities in Telemedicine
Strategic and market knowledge for implementing high-tech telemedicine applications and programmes. Latest technological developments covered. Includes profiles by company and country. Country market profiles provided for Australia, China, France, Germany, Japan, Norway, the UK and the US
Countries Covered : World
Scope : 151pp Date : 2000 Price : £ 520

Report Number : 8747-002L
Theranostics: The Influence of Diagnostics on Pharmaceutical Therapy
Examination of how this new genre of diagnostic will affect the pharmaceutical and diagnostic industries. New theranostics technologies by disease area, covering cancer, infectious diseases, diabetes, osteoporosis, Alzheimer's and arthritis. Analysis of the role of theranostics in clinical trials and profiles of the leading companies in the field
Countries Covered : World
Scope : 142pp Date : 2000 Price : £ 560

Report Number : 8747-002N
Theranostics: Now It's Getting Personal
Update to the most recent advances and opportunities in the field. Overview of major companies involved in the sector and their strategies. Latest developments in the main therapeutic areas such as genetic testing, cardiovascular disease, Alzheimer's disease and cancer, including products, developments and strategic mergers
Countries Covered : World
Scope : 116pp Date : 2002 Price : £ 750

Report Number : 8747-002P
New Trends in Viral Diagnostics
Analysis on emerging technologies, industry trends and future developments. Disease and diagnostic applications covered include: HIV; hepatitis B & C virus; herpes simplex virus; cytomegalovirus; human papilloma virus. Market profiles for the US, Japan, Germany, France, the UK, Spain and Italy, plus overview of the emerging markets of China, India, Africa and Latin America. Review of the diagnostic, pharmaceutical and biotechnology companies active in the market
Countries Covered : World
Scope : 244pp Date : 2001 Price : £ 695

Report Number : 8747-002T
Experiencing the In Vitro Diagnostics Directive
A personalised view of the In Vitro Diagnostic Directive (IVDD), coming into full effect on 8 December 2003, from the perspective of the regulatory and leading industry players. Opinions and observations of the various regulatory bodies responsible for drawing up the requirements and standards of the directive, as well as various European manufacturers. Perspective also from the US medical device industry
Countries Covered : World
Scope : 60+pp Date : 2001 Price : £ 350

Report Number : 8747-002W
The In Vitro Diagnostics Directive: A Practical Guide on How to Comply
Guide to preparing to adopt the In Vitro Diagnostic Directive (IVDD) regulations, assessing timescales of implementation and describing the key steps that companies need to take to achieve CE marking for their products
Countries Covered : World
Scope : 90pp Date : 1999 Price : £ 195

Report Number : 8747-003
Advances in Wound Management
Pipeline technologies, together with reviews of current wound care products. Includes: an introduction to wound type and the healing process; the latest developments in traditional dressings, moist dressings and wound closure products
Countries Covered : World
Scope : 150pp Date : 2002 Price : £ 750

Report Number : 8747-003C
Point of Care Markets: Home and Physician Office Testing
Strategic analysis of the global market for POC market, including information on company strategies for the leading players in glucose testing, pregnancy and fertility testing, infectious disease and drug-abuse screening testing
Countries Covered : World
Scope : 125pp Date : 2002 Price : £ 695

Report Number : 8747-004
The Worldwide Market for Cancer Diagnostics
Presents world cancer demographics and a brief discussion of the testing modalities most commonly used for the major cancer types. Worldwide market analysis provided for the main in vitro and in vivo tests used
Countries Covered : World
Scope : 328pp Date : 2002 Price : $3,500

Report Number : 8747-004A
Trends in the Early Diagnosis of Cardiovascular Disease
Worldwide Market Opportunities. Examines emerging markets and opportunities, including market size and potential. Listing of companies and organizations involved in the various market segments; company profiles
Countries Covered : World
Scope : 211pp Date : 2001 Price : $3,250

Report Number : 8747-005
In Vitro Diagnostics
Historical data (1992, 1997, 2002) and forecasts to 2007 and 2012 by product type, segment, application and market. It also presents market share data and profiles key companies
Countries Covered : World
Date : 2003 Price : $3,900

Report Number : 8747-006
CNS Markets and Therapies
Central nervous system
Countries Covered : World
Date : 2000 Price : £ 795

Report Number : 8747-007
The Cardiovascular Outlook 1998-2010
Patient potential; hypertension; hyperlipadaemia; therapeutic un-met need
Countries Covered : World
Scope : 186pp Date : 1999 Price : £ 695

Report Number : 8747-008
The CNS Outlook 1998-2010
Central nervous system; CNS disorders; Alzheimer's disease; depression; epilepsy; ADHD; migraine; multiple sclerosis; pain; Parkinson's disease; schizophrenia; stroke
Countries Covered : World
Scope : 201pp Date : 1999 Price : £ 695

Report Number : 8747-009
The Cancer Outlook 2000
Cancer therapeutics; epidemiology; breast cancer; cervical cancer; colorectal cancer; lung cancer; ovarian cancer; skin cancer; prostrate cancer
Countries Covered : World
Scope : 128pp Date : 2000 Price : £ 745

Report Number : 8747-010
The Diagnostics Outlook to 2005
Biotechnology; diagnostics companies; diagnostics market analysis and forecasts to 2005
Countries Covered : World
Scope : 150pp Date : 1999 Price : £ 495

Report Number : 8747-011
The Cardiovascular Outlook 2000
Patient potential; hypertension; hyperlipadaemia; therapeutic un-met need
Countries Covered : World
Scope : 161pp Date : 2000 Price : £ 745

Report Number : 8747-012
The CNS Outlook 2000
Central nervous system; CNS disorders; Alzheimer's disease; depression; epilepsy; ADHD; migraine; multiple sclerosis; pain; Parkinson's disease; schizophrenia; stroke
Countries Covered : World
Scope : 203pp Date : 2000 Price : £ 745

Report Number : 8747-013
Advanced Orthopedics
Base year, historical years and forecasted years for market data; key issues affecting the market; leading manufacturers and marketers of orthopedic devices
Countries Covered : World
Date : 2004 Price : On Request

Report Number : 8747-014
Ophthalmic Surgery: Worldwide and US Markets
New surgical technologies in development; the impact of industry consolidation on the shape of the market. Subsectors include LASIK, introacular lenses, extraocular procedures, retinal detachment repair, cataract repair procedures, radial keratotomy, cauterisation
Countries Covered : World
Scope : 227pp Date : 2002 Price : $1,995

Report Number : 8747-015
Successful Marketing Strategies for Medical Devices and Diagnostics
Seven stages to help the manager produce and effective strategic marketing plan
Countries Covered : World
Scope : 130pp Date : 2003 Price : $1,460

Report Number : 8747-017
Benign Prostatic Hyperplasia
Global market analysis of treatments and disease management implications.Treatments in development; current and projected market sizes worldwide for BPH drugs; the impact of DTC advertising on drug sales, patient compliance and disease management; the influence of disease management companies and health insurers on market dynamics
Countries Covered : World
Scope : 173pp Date : 2002 Price : $1,995

Report Number : 8747-018
Urinary Incontinence
World pharma market analysis and disease management impact. Impact on the market of changes in the regulatory environment; market size projections for UI drugs to 2007; impact of the growth of disease management; impact of DTC advertising on prescriptions
Countries Covered : World
Scope : 214pp Date : 2002 Price : $1,995

Report Number : 8747-019
The Sepsis Challenge
Market opportunities for novel therapies and diagnostics. Assesses the market potential of the novel diagnostic and treatment products for severe sepsis
Countries Covered : World
Scope : 100pp Date : 2001 Price : $1,040

Report Number : 8747-026
Cancer Therapy Market
Biotechnology; medical
Countries Covered : World
Scope : 25pp Date : 2003 Price : $450

Report Number : 8747-027
Intravenous Equipment
Multilumen catheters; PICC catheters; single-lumen catheters; ambulatory pump; gravity/controller pump; syringe pump; volumetric pump; gravity sets; volumetric sets; IV devices; IV kits; IV poles
Countries Covered : World
Scope : 507pp Date : 1999 Price : $2,400

Report Number : 8747-028
Radiation Therapy Equipment
Linear accelerator; Cobalt 60; treatment planning computer systems; X-ray simulators; treatment planning computers
Countries Covered : World
Scope : 238pp Date : 2000 Price : $2,450

Report Number : 8747-029
Blood Processing Supplies and Equipment
About 28 products identified and analysed
Countries Covered : World
Scope : 479pp Date : 1999 Price : $2,450

Report Number : 8747-030
Antisense Therapy: Technical Aspects and Commercial Opportunities
Antisense technologies; drug discovery; drug development; human genome; biotechnology; clinical applications
Countries Covered : World
Scope : 334pp Date : 2000 Price : £ 745

Report Number : 8747-032
Market Dynamics 1999 Cancer: Seven Country Analysis and Perspective
Countries Covered : World
Date : 1999 Price : £ 2,995

Report Number : 8747-033
International Blood/Plasma News
Newsletter; blood & plasma fractions, & biologicals: business, scientific and technological information
Countries Covered : World
Price : $430/Y Frequency : Monthly

Report Number : 8747-035
Intellectual Property Analysis of Cancer Immunotherapy
Countries Covered : World
Date : 2003 Price : $2,750

Report Number : 8747-035B
Enhancing Anticancer Therapeutics by Immunomodulation
Countries Covered : World
Date : 2003 Price : $1,950

Report Number : 8747-035D
Novel Tumour Vaccine Approaches
Countries Covered : World
Date : 2003 Price : $1,950

Report Number : 8747-035F
A Shift in Cancer Immunotherapy Strategies?
Countries Covered : World
Date : 2003 Price : $2,750

Report Number : 8747-035H
New Lines of Attack in Cancer Anti-Angiogenesis
Countries Covered : World
Date : 2003 Price : $1,950

Report Number : 8747-035J
Advancements in Colon Cancer Therapeutics
Countries Covered : World
Date : 2003 Price : $1,950

Report Number : 8747-035L
Molecular Approaches Towards HCV Therapy - The Complete Guide
Countries Covered : World
Date : 2002 Price : $1,950

Report Number : 8747-035N
Ion Channels as Therapeutic Targets for Multiple Diseases
Countries Covered : World
Date : 2002 Price : $635

Report Number : 8747-035P
Fierce Competition for a Shrinking HCV Market
Countries Covered : World
Date : 2002 Price : $675

Report Number : 8747-035R
Future Perspectives in Cancer Immunotherapy
Countries Covered : World
Date : 2002 Price : $1,950

Report Number : 8747-035T
The Competitive Landscape of Cancer Gene Therapy
Countries Covered : World
Date : 2002 Price : $1,950

Report Number : 8747-035V
Winning the Osteoporosis Therapy Race
Countries Covered : World
Date : 2003 Price : $1,950

Report Number : 8747-036
Worldwide Directory of Plasma Fractionators
Countries Covered : World
Scope : 100pp Date : 2002 Price : $595

Report Number : 8747-037
The Worldwide Market for Plasma Fractions
Existing and future market for therapeutic plasma fractions products
Countries Covered : World
Scope : 70pp Date : 2002 Price : $5,950

Report Number : 8747-039
The Plasma Fractions Market in Asia and Pacific
Existing and future market for therapeutic plasma fractions products - 3 vols.
Countries Covered : Asia, Pacific
Scope : 200pp Date : 2001 Price : $24,500/F

Report Number : 8747-040
The Treatment of Hepatitis B in Asia
Market analyis: drugs used; treatment history; patient profile; physician usage
Countries Covered : P.R. of China, Republic of Korea, Taiwan
Price : On Request Frequency : Quarterly

Report Number : 8747-040D
Gaining Reimbursement for Medical Devices and Diagnostics
How to overcome funding and reimbursement hurdles and to prove efficacy and cost-effectiveness for products and strategic guidance on pricing policies
Countries Covered : Europe, USA
Scope : 153pp Date : 2001 Price : £ 695

Report Number : 8747-042
The Plasma Fractions Market in Central and South America
Existing and future market for therapeutic plasma fractions products - 2 vols
Countries Covered : Central America, S. America
Date : 2002 Price : $16,750

Report Number : 8747-043
The Plasma Fractions Market in the Middle East
Existing and future market for therapeutic plasma fractions products
Countries Covered : Mid East
Scope : 180pp Date : 2001 Price : $12,750

Report Number : 8747-044
The Plasma Fractions Market in Africa
Existing and future market for therapeutic plasma fractions products
Countries Covered : Africa
Date : 2003 Price : $9,750

Report Number : 8747-045
The Plasma Fractions Market in Europe
Existing and future market for therapeutic plasma fractions products - 3 vols.
Countries Covered : E. Europe, W. Europe
Scope : 370pp Date : 2003 Price : $30,000/F

Report Number : 8747-046
The European Market for Organ Transplant Related Products (E3609)
Market size, growth, trends, forecasts to 2005; costs; regulatory issues;
Countries Covered : W. Europe
Date : 1999 Price : $3,950

Report Number : 8747-047
CEE Accession Countries
Opportunities for medical device and diagnostic companies. Outlines the implications EU enlargement will have on the device and diagnostics industry. Discusses key issues such as parallel trade, pricing strategies and regulatory requirements
Countries Covered : C. Europe, E. Europe
Date : 2003 Price : $1,575

Report Number : 8747-049
Euro Oncology 2003
Database of information for analysis and projection purposes about the tumour market; data presented to allow for comparison with other European countries. Three volumes: 1, Pathologies and treatments; 2, Indication analysis; 3, Agents
Countries Covered : Germany, Spain, France, Italy, UK
Scope : 460pp Date : 2003 Price : EU16,000

Report Number : 8747-050
The Treatment of Osteo-arthritis in Europe
Market analysis; drugs used; treatment history; patient profile; physician usage
Countries Covered : Germany, Spain, France, Italy, UK
Price : On Request Frequency : Quarterly

Report Number : 8747-051
The Treatment of Hepatitis C in Europe
Market analysis; drugs used; treatment history; patient profile; physician usage
Countries Covered : Germany, Spain, France, Italy, UK
Price : On Request Frequency : Quarterly

Report Number : 8747-052
The Treatment of Rheumatoid Arthritis in Europe
Market analysis; drugs used; treatment history; patient profile; physician usage
Countries Covered : Germany, Spain, France, Italy, UK
Price : On Request Frequency : Quarterly

Report Number : 8747-053
The Treatment of Diabetes in Europe
Market analysis; drugs used; treatment history; patient profile; physician usage
Countries Covered : Germany, Spain, France, Italy, UK
Price : On Request Frequency : Quarterly

Report Number : 8747-054
The Treatment of Asthma/COPD in Europe
Market analysis; drugs used; treatment history; patient profile; physician usage
Countries Covered : Germany, Spain, France, Italy, UK
Price : On Request Frequency : Quarterly

Report Number : 8747-055
Treatment of Cancer in Europe
Drugs used; treatment history; combination therapies; patient profile; physician usage & attitudes
Countries Covered : Germany, Spain, France, Italy, UK
Scope : 100pp Price : On Request Frequency : Quarterly

Report Number : 8747-056
The Plasma Fractions Market in Canada
Existing and future market for therapeutic plasma fractions products
Countries Covered : Canada
Scope : 120pp Date : 2000 Price : $2,450

Report Number : 8747-058
Hemoderivates
Countries Covered : Italy
Scope : 25pp Price : $900 Frequency : Annual

Report Number : 8747-059
Oncostat 2003
Market potential including demographics; facilities to which oncology patients are referred; oncology diseases by sex, age, location, incidence and mortality rate; treatments; trends; conditions; services offered to terminal patients
Countries Covered : Italy
Price : On Request Frequency : Annual

Report Number : 8747-061
New Zealand Medical Index (NZMI)
Quarterly syndicated audit measuring incidence & diagnosis of disease & prescribed treatment & investigations
Countries Covered : New Zealand
Scope : 2,000pp Price : NZ$35,800 Frequency : Quarterly

Report Number : 8747-064
The US Market for Fibrin Glue
Countries Covered : USA
Date : 1999 Price : $4,950

Report Number : 8747-065
Hemophilia Care & Price Monitoring, USA
Countries Covered : USA
Scope : 100pp Date : 2002 Price : $4,250

Report Number : 8747-066
Immune Globulin Intravenous (IGIV) in the Year 2005
Countries Covered : USA
Date : 2002 Price : $5,250

Report Number : 8747-067
The Plasma Fractions Market in the United States
Existing and future market for therapeutic plasma fractions products
Countries Covered : USA
Date : 2001 Price : $11,000

Report Number : 8747-071
Synthetic Oxygen Carriers (Blood Substitutes)
US markets and competitors
Countries Covered : USA
Date : 2001 Price : $4,950

Report Number : 8747-073
Private In Vitro Diagnostics Companies
Profiles of over 125 privately held companies; market share data; recent acquisitions; demand forecasts
Countries Covered : USA
Scope : 224pp Date : 2000 Price : $3,200

Report Number : 8747-077
Unstable Angina Patient Record Audit
Usage of GPIIb/IIIa agents, LMW heparin and other blood modifiers, i.e. Plavix, ASA, Ticlid, etc.; based on 1,500 patient records from over 100 hospitals; includes data on procedures such as PTCA, cardiac cath, etc.
Countries Covered : USA
Price : $37,000/Y Frequency : Twice a Year

Report Number : 8747-079
Blood Pressure Monitors
Consumer survey of health care products
Countries Covered : USA
Scope : 400pp Price : $10,000/Y Frequency : Quarterly

Report Number : 8747-080
The Plasma Fractions Market in the United States
Major quantitative & qualitative changes & developments & impact on market opportunites
Countries Covered : USA
Scope : 200pp Price : $11,750 Frequency : Annual

Report Number : 8747-081
Special In Vitro Diagnostics Research Package
Includes molecular and in vitro diagnostics; market size and share, trends, commercial outlook, profiles
Countries Covered : World
Scope : 866pp Date : 2002 Price : $8,775

Report Number : 8747-082
Current Developments in Immunotherapy Markets and Technology
Examination of the market with forecasts to 2005 for major immunotherapy products. Discussion of the use of genetic manipulation for immunomodulation
Countries Covered : USA
Scope : 357pp Date : 2001 Price : $2,812

Report Number : 8747-083
Emerging Technologies and Opportunities in Structural Tissue Engineering
Current products and products in development discussed. Key technologies, and scientific and social issues presented and discussed; market forecasts and shares for existing products and estimates for new product entries; profiles of 70+ companies
Countries Covered : USA
Scope : 450pp Date : 2001 Price : $2,437

Report Number : 8747-084
Gene Amplification Technologies: End Users, Marketers and Markets
Review of the sector, discussing technologies, applications, competitors, and regulation
Countries Covered : USA
Scope : 156pp Date : 2002 Price : $3,000

Report Number : 8747-085
The US Market for Molecular Diagnostics
Market size and share for traditional Molecular Diagnostic products and the commercial outlook for new and/or emerging technologies
Countries Covered : USA
Scope : 316pp Date : 2001 Price : $2,750

Report Number : 8747-086
Medical and Biological Sensors and Sensor Systems
Markets, applications and competitors worldwide. Remote and military biosensor applications, process and materials quality control, environmental monitoring, and food and drug quality control
Countries Covered : USA
Scope : 313pp Date : 2002 Price : $3,500

Report Number : 8747-087
The Wound Care Market
Covers 1994-2003 in four basic segments: wound care closure products, wound management products and devices, moist wound care products, biological skins and dressings. Examines economic data and regulatory environment; details market drivers, challenges and restraints; competitive analysis, market shares and complete company profiles
Countries Covered : USA
Scope : 335pp Date : 1999 Price : $3,250

Report Number : 8747-088
The Biological Response Modifier Market
Concise summary of relevant market information
Countries Covered : USA
Scope : 15pp;E Date : 2002 Price : $399

Report Number : 8747-089
The Infection Control Market in Cancer Therapy
Concise summary of relevant market information
Countries Covered : USA
Scope : 15pp;E Date : 2002 Price : $399

Report Number : 8747-090
The Cancer Pain Management Market
Concise summary of relevant market information
Countries Covered : USA
Scope : 20pp;E Date : 2002 Price : $399

Report Number : 8747-091
The Market for Other Adjunctive Therapies in Cancer
Concise summary of relevant market information
Countries Covered : USA
Scope : 19pp;E Date : 2002 Price : $399

Report Number : 8747-092
The US Market for Pain Management Pharmaceuticals
Concise summary of relevant market information
Countries Covered : USA
Scope : 15pp;E Date : 1999 Price : $299

Report Number : 8747-093
The US Market for Biological Skins and Dressings
Concise summary of relevant market information
Countries Covered : USA
Scope : 14pp;E Date : 1999 Price : $299

Report Number : 8747-094
The US Market for Wound Closure Products
Concise summary of relevant market information
Countries Covered : USA
Scope : 15pp;E Date : 1999 Price : $299

Report Number : 8747-095
Advances in Cancer Therapy
Concise summary of relevant market information
Countries Covered : USA
Scope : 16pp;E Date : 2001 Price : $399

Report Number : 8747-096
Opportunities in Immunotherapy
Concise summary of relevant market information
Countries Covered : USA
Scope : 16pp;E Date : 2001 Price : $399